@article{article, title  = {{Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{http://dx.doi.org/10.1038/s41409-023-02150-w }},

 year = {{2023}},

 month = {{12}},

 author = {{Duque-Afonso J and Finke J and Ngoya M and Galimard J-E and Craddock C and Raj K and Bloor A and Nicholson E and Eder M and Kim O and Valerius T et al}},

 doi = {{10.1038/s41409-023-02150-w}},

 journal = {{Bone Marrow Transplantation}},

 note = {{Accessed on 2024/12/22}}}